TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
NCT05257551 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-04-02
Summary
The study is a non-interventional evaluation of participants with extensive stage (ES) SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA and CTC biomarker profiling during standard of care therapy in both first and second line treatment.
Conditions
Interventions
- OTHER
-
Observation
No intervention
Sponsors & Collaborators
- collaborator INDUSTRY
- lead INDUSTRY
Principal Investigators
-
Virginia Rhodes, MD · Tempus AI, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-13
- Primary Completion
- 2029-03-31
- Completion
- 2029-03-31
Countries
- United States
Study Locations
More Related Trials
-
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529 ·Status: RECRUITING
-
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
NCT05265429 ·Status: RECRUITING
-
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
NCT02597738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
NCT01830426 ·Status: COMPLETED
-
Proteomics in Small Cell Lung Cancer
NCT05623956 ·Status: RECRUITING
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.
NCT03220230 ·Status: COMPLETED
-
Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes
NCT07215026 ·Status: COMPLETED
-
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
NCT02622581 ·Status: RECRUITING
-
Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung
NCT05987189 ·Status: RECRUITING
-
The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer
NCT02380196 ·Status: COMPLETED
-
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
NCT01052818 ·Status: UNKNOWN
-
The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC
NCT05778253 ·Status: RECRUITING
-
Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America
NCT04227457 ·Status: COMPLETED
-
Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
NCT01450553 ·Status: UNKNOWN
-
Cancer of the Lung And SeneScencE - Prospective Cohort 1
NCT06923618 ·Status: RECRUITING ·Phase: NA
-
Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging
NCT05254132 ·Status: UNKNOWN
-
Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer
NCT06907160 ·Status: RECRUITING
-
Changes in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung Cancer
NCT03746262 ·Status: COMPLETED
-
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
NCT02715102 ·Status: TERMINATED
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers
NCT00897364 ·Status: COMPLETED
-
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
NCT03628638 ·Status: COMPLETED
-
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
NCT01173458 ·Status: COMPLETED
-
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
NCT05415358 ·Status: ACTIVE_NOT_RECRUITING